Skip to main content

Psoriatic arthritis

      RT @MeralElRamahiMD: Do you use RAPID3 in PsA?

      Abst#0633 at #ACR21 shows a strong agreement between RAPID3 remission sc
      Do you use RAPID3 in PsA? Abst#0633 at #ACR21 shows a strong agreement between RAPID3 remission score w/ DAPSA + cDAPSA, esp when redefining RAPID3 categories. Is this practice △ing? With more studies to validate, yes, since RAPID3 is simpler! @RheumNow https://t.co/2q0FLeBSkC https://t.co/M3WDTGzEOT
      RT @doctorRBC: Monozygotic twin study in PsO patients showed a gut and skin microbiome difference compared to their "nor
      3 years 1 month ago
      Monozygotic twin study in PsO patients showed a gut and skin microbiome difference compared to their "normal" twin ⭐️Ruminococcus decreased/absent in gut flora of PsO ⭐️microbiome differences even in healthy PsO skin Abs#944 #ACR21 @RheumNow #ACRBest https://t.co/VlfVh5Kt3Y https://t.co/W0eSqi77lx
      First, a quick recap of how we got here. Guselkumab, an IL-23p19-subunit inhibitor, was approved for moderate to severe plaque psoriasis in July 2017. With the success of DISCOVER 1 (D1) and…
      RT @DrPetryna: Abst0944 #ACR21 #ACRBest @RheumNow microbiom evaluation of MZ twins discordant for PSO reveals Ruminococ
      3 years 1 month ago
      Abst0944 #ACR21 #ACRBest @RheumNow microbiom evaluation of MZ twins discordant for PSO reveals Ruminococcus bromii species significantly reduced & two pathways related to tetrahydrofolate biosynthesis upregulated in PSO twins compared to their unaffected siblings (p< 0.05) https://t.co/67ao0l23sI
      The RheumNow faculty have been glued to their monitors all day, watching video, and running down abstract presentations to find the best – several of these stood out as #ACRBests. Here is a…
      RT @RichardPAConway: Dr Exarchou presents incidence of PsA in Sweden. 22/100000. 75% received DMARDs within 2 years, whi
      3 years 1 month ago
      Dr Exarchou presents incidence of PsA in Sweden. 22/100000. 75% received DMARDs within 2 years, which seems high, so perhaps this is tip of iceberg with milder cases undiagnosed. Abstr#0571 #ACR21 @RheumNow https://t.co/kANG6KBnOd
      RT @swethaann23: Novel study exploring microbial differences in MZ twins discordant for psoriatic disease

      ⭐️Ruminoc
      3 years 1 month ago
      Novel study exploring microbial differences in MZ twins discordant for psoriatic disease ⭐️Ruminococcus 🔽/❎ Gut of Ps pts and maybe associated with Ps Dis ⭐️NL skin scalp of Psoriatic pts 🔽 microbial diversity compared to unaffected twins Abst#0944 #ACR21 #ACRBest @RheumNow
      RT @RichardPAConway: Dr Manasson presents on microbiome differences between monozygotic twins discordant for psoriatic d
      3 years 1 month ago
      Dr Manasson presents on microbiome differences between monozygotic twins discordant for psoriatic disease. Differences seen in gut (Ruminococcus virtually absent in psoriatic) and scalp non-lesional skin microbiomes Abstr#0944 #ACR21 @RheumNow https://t.co/8Ch0M4dwUH
      RT @ericdeinmd: #ACR21 Abst#0786. Fibroscan screening for liver injury in pts on MTX:
      ▶️No significant correlation b
      3 years 1 month ago
      #ACR21 Abst#0786. Fibroscan screening for liver injury in pts on MTX: ▶️No significant correlation between cumulative MTX dose and liver stiffness by fibroscan, even at high dose MTX. ⭐️Age, sex, waist circumference, BMI are risks @Rheumnow https://t.co/IhcNr9fhEh https://t.co/c7TUoGrNZ7
      ×